LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer
- PMID: 21482675
- PMCID: PMC3107389
- DOI: 10.1158/0008-5472.CAN-10-4167
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer
Abstract
Defective microRNA (miRNA) biogenesis contributes to the development and progression of epithelial ovarian cancer (EOC). In this study, we examined the hypothesis that single nucleotide polymorphisms (SNP) in miRNA biogenesis genes may influence EOC risk. In an initial investigation, 318 SNPs in 18 genes were evaluated among 1,815 EOC cases and 1,900 controls, followed up by a replicative joint meta-analysis of data from an additional 2,172 cases and 3,052 controls. Of 23 SNPs from 9 genes associated with risk (empirical P < 0.05) in the initial investigation, the meta-analysis replicated 6 SNPs from the DROSHA, FMR1, LIN28, and LIN28B genes, including rs12194974 (G>A), an SNP in a putative transcription factor binding site in the LIN28B promoter region (summary OR = 0.90, 95% CI: 0.82-0.98; P = 0.015) which has been recently implicated in age of menarche and other phenotypes. Consistent with reports that LIN28B overexpression in EOC contributes to tumorigenesis by repressing tumor suppressor let-7 expression, we provide data from luciferase reporter assays and quantitative RT-PCR to suggest that the inverse association among rs12194974 A allele carriers may be because of reduced LIN28B expression. Our findings suggest that variants in LIN28B and possibly other miRNA biogenesis genes may influence EOC susceptibility.
Figures


References
-
- American Cancer Society. Cancer Facts and Figures 2010. Atlanta: American Cancer Society; 2010.
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866. - PubMed
-
- Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228–234. - PubMed
-
- Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–677. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30-CA0762-92/CA/NCI NIH HHS/United States
- P50-CA-136393/CA/NCI NIH HHS/United States
- R01 CA106414/CA/NCI NIH HHS/United States
- R01-CA-63682/CA/NCI NIH HHS/United States
- CA-54419/CA/NCI NIH HHS/United States
- DH_/Department of Health/United Kingdom
- R01 CA063678/CA/NCI NIH HHS/United States
- P50 CA105009/CA/NCI NIH HHS/United States
- A10119/CRUK_/Cancer Research UK/United Kingdom
- P30 CA076292/CA/NCI NIH HHS/United States
- R01-CA114343-S1/CA/NCI NIH HHS/United States
- R01-CA-106414/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- R01-CA-114343/CA/NCI NIH HHS/United States
- G0801875/MRC_/Medical Research Council/United Kingdom
- R01 CA054419/CA/NCI NIH HHS/United States
- R01-CA-122443/CA/NCI NIH HHS/United States
- R01 CA122443/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- R01-CA-63678/CA/NCI NIH HHS/United States
- R01 CA076016/CA/NCI NIH HHS/United States
- P30-CA-15083/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- R01 CA063682/CA/NCI NIH HHS/United States
- R01-CA-76016/CA/NCI NIH HHS/United States
- A10124/CRUK_/Cancer Research UK/United Kingdom
- R01 CA114343/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials